VR Adviser, LLC Q4 2022 Filing
Filed February 14, 2023
Portfolio Value
$622.9B
Holdings
29
Report Date
Q4 2022
Filing Type
13F-HR
All Holdings (29 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | VRDNVIRIDIAN THERAPEUTICS INC | 2,699,865 | $78K | 0.00% | |
| 2 | ACRSACLARIS THERAPEUTICS INC | 4,563,962 | $71K | 0.00% | |
| 3 | AXSMAXSOME THERAPEUTICS INC | 670,718 | $51K | 0.00% | |
| 4 | COGTCOGENT BIOSCIENCES INC | 4,038,117 | $46K | 0.00% | |
| 5 | TERNTERNS PHARMACEUTICALS INC | 3,707,891 | $37K | 0.00% | |
| 6 | GHRSGH RESEARCH PLC | 3,517,125 | $34K | 0.00% | |
| 7 | —DBV TECHNOLOGIES S A | 9,300,000 | $29K | 0.00% | |
| 8 | CELCCELCUITY INC | 2,105,386 | $29K | 0.00% | |
| 9 | —DICE THERAPEUTICS INC | 819,000 | $25K | 0.00% | |
| 10 | AVTEAEROVATE THERAPEUTICS INC | 747,869 | $21K | 0.00% | |
| 11 | PLRXPLIANT THERAPEUTICS INC | 1,080,000 | $20K | 0.00% | |
| 12 | NVV1NOVAVAX INC | 1,879,894 | $19K | 0.00% | |
| 13 | KALVKALVISTA PHARMACEUTICALS INC | 2,916,667 | $19K | 0.00% | |
| 14 | MRUSMERUS N V | 1,226,214 | $18K | 0.00% | |
| 15 | CABACABALETTA BIO INC | 1,895,285 | $17K | 0.00% | |
| 16 | —VECTIVBIO HLDG AG | 1,866,000 | $16K | 0.00% | |
| 17 | ANNXANNEXON INC | 3,220,050 | $16K | 0.00% | |
| 18 | PRVBUSDPROVENTION BIO INC | 1,118,653 | $11K | 0.00% | |
| 19 | YB4PSAVARA INC | 6,351,531 | $9K | 0.00% | |
| 20 | MISTMILESTONE PHARMACEUTICALS IN | 2,208,812 | $8K | 0.00% | |
| 21 | MRNS*MARINUS PHARMACEUTICALS INC | 1,770,705 | $7K | 0.00% | |
| 22 | LIANYLIANBIO | 4,793,047 | $7K | 0.00% | |
| 23 | TRVITREVI THERAPEUTICS INC | 3,050,022 | $5K | 0.00% | |
| 24 | FULCFULCRUM THERAPEUTICS INC | 447,326 | $3K | 0.00% | |
| 25 | LYRALYRA THERAPEUTICS INC | 924,170 | $2K | 0.00% | |
| 26 | INZYINOZYME PHARMA INC | 2,709,987 | $2K | 0.00% | |
| 27 | ATYRATYR PHARMA INC | 1,171,436 | $2K | 0.00% | |
| 28 | RLYBRALLYBIO CORP | 268,532 | $1K | 0.00% | |
| 29 | —AFFIMED N V | 1,428,571 | $1K | 0.00% |